The clinical trial results discussed above and presented in Table 5 demonstrate that ovarian function suppression ablation plus tamoxifen is at least as effective as chemotherapy for premenopausal patients with ER positive disease [Only registered and activated users can see links. Click Here To Register...] Source Kulier et al
